Comprehensive Clinical Nephrology Update and ABIM Board Review from Harvard Medical School
Harvard Intensive Review of Nephrology 2026 is a comprehensive online CME program designed to provide an intensive review of current nephrology practice while supporting preparation for the ABIM Nephrology Certification and Recertification examinations. Featuring more than 70 interactive lectures, clinical case discussions, board preparation sessions, and supplementary presentations, the course covers both foundational principles and important advances across the full spectrum of kidney disease.
Led by experts in their respective fields, the program addresses electrolytes and acid-base disorders, glomerulonephritis, acute kidney injury, chronic kidney disease, genetic and vascular kidney disease, hypertension, end-stage kidney disease, dialysis, transplantation, onconephrology, pregnancy and renal disease, and point-of-care renal ultrasound. The 2026 curriculum also highlights genetic testing, SGLT2 inhibitors, GLP-1 agonists, finerenone, novel immunosuppressive therapies, CAR-T therapy, xenotransplantation, conservative kidney management, renal palliative care, and artificial intelligence in nephrology.
* Original Event Dates: August 10–14, 2026
LEARNING OBJECTIVES Upon completion of this course, participants will be able to:
HARVARD INTENSIVE REVIEW OF NEPHROLOGY 2026







